TY - JOUR AU - Hajarizadeh, B. AU - Grebely, J. AU - Dore, G. J. PY - 2013 DA - 2013// TI - Epidemiology and natural history of HCV infection JO - Nat Rev Gastroenterol Hepatol. VL - 10 UR - https://doi.org/10.1038/nrgastro.2013.107 DO - 10.1038/nrgastro.2013.107 ID - Hajarizadeh2013 ER - TY - JOUR AU - Zeremski, M. AU - Dimova, R. B. AU - Pillardy, J. AU - Jong, Y. P. AU - Jacobson, I. M. AU - Talal, A. H. PY - 2016 DA - 2016// TI - Fibrosis progression in patients with chronic hepatitis C virus infection JO - J Infect Dis. VL - 214 UR - https://doi.org/10.1093/infdis/jiw332 DO - 10.1093/infdis/jiw332 ID - Zeremski2016 ER - TY - JOUR AU - Vescovo, T. AU - Refolo, G. AU - Vitagliano, G. AU - Fimia, G. M. AU - Piacentini, M. PY - 2016 DA - 2016// TI - Molecular mechanisms of hepatitis C virus-induced hepatocellular carcinoma JO - Clin Microbiol Infect. VL - 22 UR - https://doi.org/10.1016/j.cmi.2016.07.019 DO - 10.1016/j.cmi.2016.07.019 ID - Vescovo2016 ER - TY - JOUR AU - Lanini, S. AU - Easterbrook, P. J. AU - Zumla, A. AU - Ippolito, G. PY - 2016 DA - 2016// TI - Hepatitis C: global epidemiology and strategies for control JO - Clin Microbiol Infect. VL - 22 UR - https://doi.org/10.1016/j.cmi.2016.07.035 DO - 10.1016/j.cmi.2016.07.035 ID - Lanini2016 ER - TY - JOUR AU - Cacoub, P. AU - Comarmond, C. AU - Domont, F. AU - Savey, L. AU - Desbois, A. C. AU - Saadoun, D. PY - 2016 DA - 2016// TI - Extrahepatic manifestations of chronic hepatitis C virus infection JO - Ther Adv Infect Dis. VL - 3 UR - https://doi.org/10.1177/2049936115585942 DO - 10.1177/2049936115585942 ID - Cacoub2016 ER - TY - JOUR AU - Agnello, V. AU - Chung, R. T. AU - Kaplan, L. M. PY - 1992 DA - 1992// TI - A role for hepatitis C virus infection in type II cryoglobulinemia JO - N Engl J Med. VL - 327 UR - https://doi.org/10.1056/NEJM199211193272104 DO - 10.1056/NEJM199211193272104 ID - Agnello1992 ER - TY - JOUR AU - Dammacco, F. AU - Sansonno, D. PY - 1992 DA - 1992// TI - Antibodies to hepatitis C virus in essential mixed cryoglobulinaemia JO - Clin Exp Immunol. VL - 87 UR - https://doi.org/10.1111/j.1365-2249.1992.tb03001.x DO - 10.1111/j.1365-2249.1992.tb03001.x ID - Dammacco1992 ER - TY - JOUR AU - Dammacco, F. AU - Sansonno, D. AU - Piccoli, C. AU - Racanelli, V. AU - D’Amore, F. P. AU - Lauletta, G. PY - 2000 DA - 2000// TI - The lymphoid system in hepatitis C virus infection: autoimmunity, mixed cryoglobulinemia, and overt B-cell malignancy JO - Semin Liver Dis. VL - 20 UR - https://doi.org/10.1055/s-2000-9613 DO - 10.1055/s-2000-9613 ID - Dammacco2000 ER - TY - JOUR AU - Dammacco, F. AU - Racanelli, V. AU - Russi, S. AU - Sansonno, D. PY - 2016 DA - 2016// TI - The expanding spectrum of HCV-related cryoglobulinemic vasculitis: a narrative review JO - Clin Exp Med. VL - 16 UR - https://doi.org/10.1007/s10238-016-0410-9 DO - 10.1007/s10238-016-0410-9 ID - Dammacco2016 ER - TY - JOUR AU - Lauletta, G. AU - Russi, S. AU - Conteduca, V. AU - Sansonno, L. PY - 2012 DA - 2012// TI - Hepatitis C virus infection and mixed cryoglobulinemia JO - Clin Dev Immunol. VL - 2012 UR - https://doi.org/10.1155/2012/502156 DO - 10.1155/2012/502156 ID - Lauletta2012 ER - TY - JOUR AU - Lauletta, G. AU - Russi, S. AU - Conteduca, V. AU - Sansonno, L. AU - Dammacco, F. AU - Sansonno, D. PY - 2013 DA - 2013// TI - Impact of cryoglobulinemic syndrome on the outcome of chronic hepatitis C virus infection JO - Medicine (Baltimore) VL - 92 UR - https://doi.org/10.1097/MD.0b013e31829d2abc DO - 10.1097/MD.0b013e31829d2abc ID - Lauletta2013 ER - TY - JOUR AU - Bonomo, L. AU - Casato, M. AU - Afeltra, A. AU - Caccavo, D. PY - 1987 DA - 1987// TI - Treatment of idiopathic mixed cryoglobulinemia with alpha interferon JO - Am J Med. VL - 83 UR - https://doi.org/10.1016/0002-9343(87)90904-1 DO - 10.1016/0002-9343(87)90904-1 ID - Bonomo1987 ER - TY - JOUR AU - Casato, M. AU - Laganà, B. AU - Antonelli, G. AU - Dianzani, F. AU - Bonomo, L. PY - 1991 DA - 1991// TI - Long-term results of therapy with interferon-α for type II essential mixed cryoglobulinemia JO - Blood. VL - 78 ID - Casato1991 ER - TY - JOUR AU - Dammacco, F. AU - Sansonno, D. PY - 2013 DA - 2013// TI - Therapy for hepatitis C virus-related cryoglobulinemic vasculitis JO - N Engl J Med. VL - 369 UR - https://doi.org/10.1056/NEJMra1208642 DO - 10.1056/NEJMra1208642 ID - Dammacco2013 ER - TY - JOUR AU - Cacoub, P. AU - Saadoun, D. AU - Limal, N. AU - Sene, D. AU - Lidove, O. AU - Piette, J. C. PY - 2005 DA - 2005// TI - PEGylated interferon alfa-2b and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis JO - Arthritis Rheum. VL - 52 UR - https://doi.org/10.1002/art.20958 DO - 10.1002/art.20958 ID - Cacoub2005 ER - TY - JOUR AU - Mazzaro, C. AU - Monti, G. AU - Saccardo, F. AU - Zignego, A. L. AU - Ferri, C. AU - Vita, S. PY - 2011 DA - 2011// TI - Efficacy and safety of peginterferon alfa-2b plus ribavirin for HCV-positive mixed cryoglobulinemia: a multicentre open-label study JO - Clin Exp Rheumatol. VL - 29 ID - Mazzaro2011 ER - TY - JOUR AU - Sansonno, D. AU - Re, V. AU - Lauletta, G. AU - Tucci, F. A. AU - Boiocchi, M. AU - Dammacco, F. PY - 2003 DA - 2003// TI - Monoclonal antibody treatment of mixed cryoglobulinemia resistant to interferon α with an anti-CD20 JO - Blood. VL - 101 UR - https://doi.org/10.1182/blood-2002-10-3162 DO - 10.1182/blood-2002-10-3162 ID - Sansonno2003 ER - TY - JOUR AU - Zaja, F. AU - Vita, S. AU - Mazzaro, C. AU - Sacco, S. AU - Damiani, D. AU - Marchi, G. PY - 2003 DA - 2003// TI - Efficacy and safety of rituximab in type II mixed cryoglobulinemia JO - Blood. VL - 101 UR - https://doi.org/10.1182/blood-2002-09-2856 DO - 10.1182/blood-2002-09-2856 ID - Zaja2003 ER - TY - JOUR AU - Dammacco, F. AU - Tucci, F. A. AU - Lauletta, G. AU - Gatti, P. AU - Re, V. AU - Conteduca, V. PY - 2010 DA - 2010// TI - Pegylated interferon-α, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study JO - Blood. VL - 116 UR - https://doi.org/10.1182/blood-2009-10-245878 DO - 10.1182/blood-2009-10-245878 ID - Dammacco2010 ER - TY - JOUR AU - Saadoun, D. AU - Resche Rigon, M. AU - Pol, S. AU - Thibault, V. AU - Blanc, F. AU - Pialoux, G. PY - 2015 DA - 2015// TI - PegIFNα/ribavirin/protease inhibitor combination in severe hepatitis C virus-associated mixed cryoglobulinemia vasculitis JO - J Hepatol. VL - 62 UR - https://doi.org/10.1016/j.jhep.2014.08.015 DO - 10.1016/j.jhep.2014.08.015 ID - Saadoun2015 ER - TY - JOUR AU - Zhang, J. AU - Nguyen, D. AU - Hu, K. Q. PY - 2016 DA - 2016// TI - Chronic hepatitis C virus infection: a review of current direct-acting antiviral treatment strategies JO - N Am J Med Sci (Boston) VL - 9 ID - Zhang2016 ER - TY - JOUR PY - 2017 DA - 2017// TI - EASL recommendations on treatment of hepatitis C 2016 JO - J Hepatol VL - 66 UR - https://doi.org/10.1016/j.jhep.2016.09.001 DO - 10.1016/j.jhep.2016.09.001 ID - ref22 ER - TY - JOUR PY - 2015 DA - 2015// TI - Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus JO - Hepatology VL - 62 UR - https://doi.org/10.1002/hep.27950 DO - 10.1002/hep.27950 ID - ref23 ER - TY - JOUR AU - Saadoun, D. AU - Thibault, V. AU - Si Ahmed, S. N. AU - Alric, L. AU - Mallet, M. AU - Guillaud, C. PY - 2016 DA - 2016// TI - Sofosbuvir plus ribavirin for hepatitis C virus-associated cryoglobulinaemia vasculitis: VASCUVALDIC study JO - Ann Rheum Dis. VL - 75 UR - https://doi.org/10.1136/annrheumdis-2015-208339 DO - 10.1136/annrheumdis-2015-208339 ID - Saadoun2016 ER - TY - JOUR AU - Sise, M. E. AU - Bloom, A. K. AU - Wisocky, J. AU - Lin, M. V. AU - Gustafson, J. L. AU - Lundquist, A. L. PY - 2016 DA - 2016// TI - Treatment of hepatitis C virus-associated mixed cryoglobulinemia with direct-acting antiviral agents JO - Hepatology. VL - 63 UR - https://doi.org/10.1002/hep.28297 DO - 10.1002/hep.28297 ID - Sise2016 ER - TY - JOUR AU - Gragnani, L. AU - Visentini, M. AU - Fognani, E. AU - Urraro, T. AU - Santis, A. AU - Petraccia, L. PY - 2016 DA - 2016// TI - Prospective study of guideline-tailored therapy with direct-acting antivirals for hepatitis C virus-associated mixed cryoglobulinemia JO - Hepatology. VL - 64 UR - https://doi.org/10.1002/hep.28753 DO - 10.1002/hep.28753 ID - Gragnani2016 ER - TY - STD TI - Bonacci M, Lens S, Londoño MC, Mariño Z, Cid MC, Ramos-Casals M, et al. Virologic, clinical, and immune response outcomes of patients with hepatitis C virus-associated cryoglobulinemia treated with direct-acting antivirals. Clin Gastroenterol Hepatol. doi:10.1016/j.cgh.2016.09.158. ID - ref27 ER - TY - JOUR AU - Quartuccio, L. AU - Isola, M. AU - Corazza, L. AU - Ramos-Casals, M. AU - Retamozo, S. AU - Ragab, G. M. PY - 2014 DA - 2014// TI - Validation of the classification criteria for cryoglobulinaemic vasculitis JO - Rheumatology (Oxford) VL - 53 UR - https://doi.org/10.1093/rheumatology/keu271 DO - 10.1093/rheumatology/keu271 ID - Quartuccio2014 ER - TY - JOUR AU - Brouet, J. C. AU - Clauvel, J. P. AU - Danon, F. AU - Klein, M. AU - Seligmann, M. PY - 1974 DA - 1974// TI - Biologic and clinical significance of cryoglobulins: a report of 86 cases JO - Am J Med. VL - 57 UR - https://doi.org/10.1016/0002-9343(74)90852-3 DO - 10.1016/0002-9343(74)90852-3 ID - Brouet1974 ER - TY - JOUR AU - Musset, L. AU - Diemert, M. C. AU - Taibi, F. AU - Thi Huong, L. AU - Cacoub, P. AU - Leger, J. M. PY - 1992 DA - 1992// TI - Characterization of cryoglobulins by immunoblotting JO - Clin Chem VL - 38 ID - Musset1992 ER - TY - JOUR AU - Trejo, O. AU - Ramos-Casals, M. AU - García-Carrasco, M. AU - Yagüe, J. AU - Jiménez, S. AU - Red, G. PY - 2001 DA - 2001// TI - Cryoglobulinemia: study of etiologic factors and clinical and immunologic features in 443 patients from a single center JO - Medicine (Baltimore) VL - 80 UR - https://doi.org/10.1097/00005792-200107000-00004 DO - 10.1097/00005792-200107000-00004 ID - Trejo2001 ER - TY - JOUR AU - Sollima, S. AU - Milazzo, L. AU - Peri, A. M. AU - Torre, A. AU - Antinori, S. AU - Galli, M. PY - 2016 DA - 2016// TI - Persistent mixed cryoglobulinaemia vasculitis despite hepatitis C virus eradication after interferon-free antiviral therapy JO - Rheumatology (Oxford) VL - 55 UR - https://doi.org/10.1093/rheumatology/kew268 DO - 10.1093/rheumatology/kew268 ID - Sollima2016 ER - TY - JOUR AU - Hartridge-Lambert, S. K. AU - Stein, E. M. AU - Markowitz, A. J. AU - Portlock, C. S. PY - 2012 DA - 2012// TI - Hepatitis C and non-Hodgkin lymphoma: the clinical perspective JO - Hepatology. VL - 55 UR - https://doi.org/10.1002/hep.25499 DO - 10.1002/hep.25499 ID - Hartridge-Lambert2012 ER - TY - JOUR AU - Arcaini, L. AU - Vallisa, D. AU - Rattotti, S. AU - Ferretti, V. V. AU - Ferreri, A. J. M. AU - Bernuzzi, P. PY - 2014 DA - 2014// TI - Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi JO - Ann Oncol. VL - 25 UR - https://doi.org/10.1093/annonc/mdu166 DO - 10.1093/annonc/mdu166 ID - Arcaini2014 ER - TY - JOUR AU - Arcaini, L. AU - Besson, C. AU - Frigeni, M. AU - Fontaine, H. AU - Goldaniga, M. AU - Casato, M. PY - 2016 DA - 2016// TI - Interferon-free antiviral treatment in B-cell lymphoproliferative disorders associated with hepatitis C virus infection JO - Blood. VL - 128 UR - https://doi.org/10.1182/blood-2016-05-714667 DO - 10.1182/blood-2016-05-714667 ID - Arcaini2016 ER - TY - JOUR AU - Torres, H. A. AU - McDonald, G. B. PY - 2016 DA - 2016// TI - How I treat hepatitis C virus infection in patients with hematologic malignancies JO - Blood. VL - 128 UR - https://doi.org/10.1182/blood-2016-05-718643 DO - 10.1182/blood-2016-05-718643 ID - Torres2016 ER - TY - JOUR AU - Saadoun, D. AU - Resche-Rigon, M. AU - Thibault, V. AU - Piette, J. C. AU - Cacoub, P. PY - 2006 DA - 2006// TI - Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a long-term follow-up study JO - Arthritis Rheum. VL - 54 UR - https://doi.org/10.1002/art.22168 DO - 10.1002/art.22168 ID - Saadoun2006 ER - TY - JOUR AU - Reyes-Avilés, E. AU - Kostadinova, L. AU - Rusterholtz, A. AU - Cruz-Lebrón, A. AU - Falck-Ytter, Y. AU - Anthony, D. D. PY - 2015 DA - 2015// TI - Presence of rheumatoid factor during chronic HCV infection is associated with expansion of mature activated memory B-cells that are hypo-responsive to B-cell receptor stimulation and persist during the early stage of IFN free therapy JO - PLoS One. VL - 10 UR - https://doi.org/10.1371/journal.pone.0144629 DO - 10.1371/journal.pone.0144629 ID - Reyes-Avilés2015 ER -